,28 Recently, we demonstrated that OBP-702-mediated p53 overexpression induces marked ICD that enhances the efficacy of PD-1 blockade against p53-wild-type and p53-mutant pancreatic cancer cells.29 This evidence concerns the gene TP53 and pancreatic neoplasm.